Cancer Radiotherapie

Papers
(The TQCC of Cancer Radiotherapie is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Issue Contents19
Hypofractionated radiotherapy in the management of rectal tumours18
Quality of weight loss during chemoradioherapy in patients with nasopharyngeal cancers16
Role of radiotherapy in the management of rare solid thoracic tumors of the adults13
Can we predict the cardiac benefit of deep inspiration breath hold for left breast and regional nodal irradiation?13
Contribution of chemotherapy in immunoradiotherapy combinations12
Neoadjuvant treatment of pancreatic adenocarcinoma: Chemoradiation or stereotactic body radiation therapy?11
Assurance qualité de la radiothérapie en recherche clinique11
Editorial Board11
Extra- and intracranial schwannomas treated with fractionated stereotactic irradiation: Results of a retrospective, multicentric study11
Prognostic factors for 495 nonoperative esophageal squamous cancer patients receiving IMRT plus chemotherapy: A retrospective analysis11
Effets secondaires endocriniens de la radiothérapie : diagnostic, prévention et traitements10
Nuclear protein in testis (NUT) midline carcinoma of the larynx: A rare case report of a paediatric patient and literature review10
Radiation therapy in the thoracic region: Radio-induced cardiovascular disease, cardiac delineation and sparing, cardiac dose constraints, and cardiac implantable electronic devices10
Surface-guided radiotherapy overview: Technical aspects and clinical applications9
Use of nanoparticles in radiation oncology8
Issue Contents8
Stereotactic magnetic resonance imaging-guided radiotherapy for intracardiac metastases: A case report8
Role of radiotherapy in the management of testicular cancer: Recommendations from the French society for radiation oncology8
Radiotherapy of breast cancer: 2025 update8
Outcomes of adjuvant lymph node field radiotherapy and immunotherapy for stage III melanoma8
Stereotactic body radiation therapy for liver metastases in oligometastatic disease8
Études qui changent les pratiques en oncoradiothérapie digestive8
Role of autophagy in modulating tumor cell radiosensitivity: Exploring pharmacological interventions for glioblastoma multiforme treatment8
Stereotactic body radiation therapy for bone oligometastases7
Analyse de l’impact des résultats du séquençage de nouvelle génération chez les patients atteints de glioblastome7
Comprehensive commissioning and quality assurance validation of Ethos™ therapy7
First experiences with an adaptive pelvic radiotherapy system: Analysis of treatment times and learning curve7
La radiothérapie stéréotaxique au Maroc : état des lieux et compatibilité technologique avec les exigences minimales des recommandations internationales de bonne pratique7
Evolution of radiation oncology training in France: Over 20 years of the role of the Société française des jeunes radiothérapeutes oncologues (SFjRO, the French society of young radiation oncologists)7
Dosimetric comparison of advanced radiotherapy planning techniques for hippocampal sparing whole brain radiotherapy7
Étude de faisabilité : l’utilisation de l’imagerie médicale en éducation thérapeutique en radiothérapie7
Radiotherapy of skin cancers7
Réirradiation des récidives de carcinomes mammaires6
Editorial Board6
Radiotherapy for nasopharyngeal cancer: 2025 update6
Comprehensive analysis of uveal mucosa-associated lymphoid tissue lymphomas: Epidemiological insights and radiotherapy utilization from the Surveillance, Epidemiology and End Results database6
Radiotherapy for oral cavity cancers: 2025 update6
Qualitative evaluation of automatic liver segmentation in computed tomography images for clinical use in radiation therapy6
Thoracic reirradiation of recurrent non-small cell lung carcinoma: A comprehensive review6
Quality control of postoperative radiotherapy for non-small cell lung cancer: A study of mediastinal shift6
Insights on the carbon footprint of radiotherapy in France6
Breast cancer in a transgender man and hypofractionated radiotherapy: A case report and review of literature6
News in magnetic resonance imaging use for radiation oncology6
Role of radiotherapy in the management of brain oligometastases6
Metastasis-directed radiotherapy for non-small cell lung cancer failured under TKI: A case report and literature review6
Dosimetric comparison of different intensity-modulated radiotherapy techniques for whole-breast irradiation of right-breast cancer6
Combinaison de la radiothérapie interne vectorisée et de la radiothérapie externe6
Fibrose pulmonaire radio-induite : nouvelles cibles pour demain6
Editorial Board6
RecoRad™ 4th edition: The Société française de radiothérapie oncologique's “Recommendations” Commission-driven RecoRad™ 2025 updated version5
Long-term cardiac mortality in patients treated with radiation for gastric mucosa-associated lymphoid tissue lymphoma5
Application of intraoperative radiotherapy for malignant glioma5
Transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma: Long-term results of RTF3 regimen5
Limites de la définition des contraintes de dose pour les organes à risque spécifiques à la radiothérapie stéréotaxique5
Role of radiotherapy in the management of anal canal cancer: Recommendations of the Société française de radiothérapie oncologique5
Issue Contents5
Hypofractionated radiotherapy for invasive squamous cell carcinoma of the scalp in the elderly: Efficacy and tolerance, preliminary results5
Editorial Board5
Hypofractionated radiotherapy for pancreatic cancer: What role in 2025?5
Failure patterns analysis of three-dimensional radiotherapy for stage IV non-small cell lung cancer primary tumours5
Spontaneous resolution of intracranial hypertension following radiotherapy for posterior parasagittal meningioma: About two cases and review of the literature5
Tumeurs rares du sein5
Role of stereotactic radiotherapy in the management of small-cell lung cancer5
Delineation of organs at risk in radiotherapy and perspectives5
Comments on “Ocular proton therapy, pencil beam scanning high energy proton therapy or stereotactic radiotherapy for uveal melanoma; an in silico study”5
Radiation therapy of the primary tumour and/or metastases of digestive metastatic cancers5
Guide for paediatric radiotherapy procedures: 2025 update5
Radiation therapist, a key player in radiotherapy research4
Voxel-wise analysis: A powerful tool to predict radio-induced toxicity and potentially perform personalised planning in radiotherapy4
Preoperative ultra-hypofractionation radiotherapy in extremity/trunk wall soft tissue sarcoma — A meta-analysis of prospective studies4
Impact of radiotherapy schedule on survival of patients treated with immune-checkpoint inhibitors for advanced melanoma and non-small cell lung cancer4
Breast cancer tumour board: Which patients are eligible for radiotherapy de-escalation or omission?4
Adaptive radiotherapy4
Issue Contents4
Patterns of relapse after postoperative radiotherapy in patients with oral cavity cancer and a flap4
Hypofractionated radiotherapy in the management of bladder cancer4
External beam radiotherapy for prostatic cancers: 2025 update4
Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed radiotherapy4
Could conventionally fractionated radiation therapy coupled with stereotactic body radiation therapy improve local control in bone oligometastases?4
Is hypofractionated radiotherapy used to treat soft tissue sarcomas? Assessment of practices using the NETSARC network3
Practice-changing clinical trials in radiation oncology: A 2024–2025 literature synthesis3
Radiotherapy and CDK inhibitors: Opportunities and risks3
What is the future of uterovaginal brachytherapy in private practice in France?3
Radiotherapy for rare primary brain tumors3
Myonecrosis as a rare side effect of stereotactic body radiotherapy for bone metastases: Report of two cases and a comprehensive literature review3
Radiotherapy for hypopharynx cancers: 2025 update3
What effective technique to differentiate radiation brain necrosis from a tumor progression in patients treated with radiation: A monocentric retrospective study combining the MRI TRAMs technique and 3
Observation of the efficacy and safety of concurrent intensity-modulated radiation with 5-fluorouracil and oxaliplatin for locally advanced nasopharyngeal carcinoma3
Radiotherapy in the management of synchronous metastatic lung cancer3
Complementary therapies: What are we talking about?3
Orbital follicular lymphoma with large cell component treated with low-dose radiotherapy: A case report and review of literature3
Moderate versus ultra-hypofractionated locoregional breast radiotherapy: Results of a retrospective study during the covid-19 era3
Prognostic significance of different lymph node staging systems in patients with resectable, node-positive, stage III, non-small cell lung cancer: Identifying the optimal classification for enhanced p3
Preoperative stereotactic radiotherapy for the management of brain metastases3
Comparative study of interstitial brachytherapy and intensity-modulated radiotherapy as tumour bed boost after conservative surgery for breast cancer: Toxicity and cosmetic outcomes3
Technological innovations in head and neck radiotherapy: What does the future hold?3
Management of cervical lymphadenopathies of unknown primary cancer3
Cancer de l’endomètre de stade localisé : la perspective d’une désescalade thérapeutique guidée par la classification moléculaire3
Defining the potential for sexual structures-sparing for prostate cancer external beam radiotherapy: A dosimetric study3
Acute toxicity in patients with high-risk prostate cancer treated with stereotactic body radiation, with irradiation to the prostate and pelvic nodes3
Radiotherapy of bone metastases: 2025 update3
The QuADRANT project: Enhancing quality and safety in radiological procedures through clinical audit3
Contents3
Editorial Board3
Postoperative radiotherapy in prostate cancer: When and how? – An update review3
Radiotherapy of salivary gland tumours: 2025 update3
Stereotactic body radiotherapy for mediastinal lymph node with CyberKnife®: Efficacy and toxicity3
The role of radiation therapy for de novo metastatic bladder and renal cancers3
Radiotherapy for primary lung cancer: 2025 update3
Chemoimmunotherapy for localized non-small cell lung cancer: A new standard for all stage III?3
Editorial Board3
Health-related quality of life and cognitive failures in patients with lower-grade gliomas treated with radiotherapy3
Pathologie hématologique : le modèle le plus abouti de désescalade en radiothérapie3
Contemporary survival outcomes of patients with isolated nodal recurrences of breast cancer: A population-based study3
Head and neck cancers volume reduction: should we reduce our prophylactic node radiation to spare the antitumor immune response?3
Dose-escalation in prostate cancer: Results of randomized trials3
Multicriteria optimization of radiation therapy: Towards empowerment and standardization of reverse planning for head and neck squamous cell carcinoma3
Radiotherapy and pregnancy: 2025 update3
Management and work-up procedures of patients with head and neck malignancies treated by radiation: 2025 update3
Permanent alopecia after radiotherapy of primary brain tumours: The most influential factors3
Kinetics of plasma cell-free DNA as a prospective biomarker to predict the prognosis and radiotherapy effect of esophageal cancer3
Issue Contents3
Radiotherapy: Beyond cancer…3
Issue Contents3
Influence de l’immunothérapie sur le choix du traitement des cancers bronchiques non à petites cellules de stade I : point de vue de l’oncologue radiothérapeute3
Artificial intelligence solution to accelerate the acquisition of MRI images: Impact on the therapeutic care in oncology in radiology and radiotherapy departments3
Que faut-il pour faire de la radiothérapie adaptative « online » ?3
Place de la radiothérapie stéréotaxique pour les cancers bronchiques non à petites cellules de stade I opérables3
Interstitial brachytherapy for lip carcinomas: Comparison between Ir-192 low-dose-rate and high-dose-rate treatment3
Hypofractionated postoperative stereotactic radiotherapy for large resected brain metastases3
Aspects biologiques, précliniques et cliniques de l’association de radiothérapie et d’inhibiteur de CDK 4/63
Interactions endothélium vasculaire – cellules immunitaires : un point de contrôle clef des lésions digestives radio-induites3
Evaluating ChatGPT to test its robustness as an interactive information database of radiation oncology and to assess its responses to common queries from radiotherapy patients: A single institution in3
Radiotherapy needs in French-speaking low- and middle-income countries: Overcoming language barriers for equitable cancer care3
0.51445484161377